Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2013; 19(30): 4925-4934
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4925
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4925
Figure 5 Tumor necrosis factor-α mediated ischemia-reperfusion-induced mucosal apoptosis via caspase activation in intestinal mucosa.
Total protein was extracted from intestinal mucosa, and subjected to SDS-PAGE and Western blotting analysis. β-actin was used as the control for loading. The results were expressed as a ratio to β-actin densitometry units. A: Western blotting analysis; B: The ratio of cleaved caspase-9 and β-actin; C: The ratio of cleaved caspase-3 and β-actin. Values are mean ± SE. Six rats were tested in each group. aP < 0.05 vs sham-operation (SO) rats pretreated with vehicle (SO + vehicle); cP < 0.05 vs ischemia-reperfusion(I/R) rats pretreated with vehicle (ischemia-reperfusion + vehicle). PTX: Pentoxifylline; IFX: Infliximab.
- Citation: Yang Q, Zheng FP, Zhan YS, Tao J, Tan SW, Liu HL, Wu B. Tumor necrosis factor-α mediates JNK activation response to intestinal ischemia-reperfusion injury. World J Gastroenterol 2013; 19(30): 4925-4934
- URL: https://www.wjgnet.com/1007-9327/full/v19/i30/4925.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i30.4925